Page last updated: 2024-09-05

fr 7534 and dipyridamole

fr 7534 has been researched along with dipyridamole in 3 studies

Compound Research Comparison

Studies
(fr 7534)
Trials
(fr 7534)
Recent Studies (post-2010)
(fr 7534)
Studies
(dipyridamole)
Trials
(dipyridamole)
Recent Studies (post-2010) (dipyridamole)
10007,826881632

Protein Interaction Comparison

ProteinTaxonomyfr 7534 (IC50)dipyridamole (IC50)
90-kda heat shock protein beta HSP90 beta, partialHomo sapiens (human)21.0682
heat shock protein HSP 90-alpha isoform 2Homo sapiens (human)21.0682
cGMP-dependent 3',5'-cyclic phosphodiesteraseHomo sapiens (human)3.1233
Solute carrier family 22 member 2Homo sapiens (human)2.6
Multidrug resistance-associated protein 4Homo sapiens (human)5.15
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8AHomo sapiens (human)2.6333
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)1.9708
3',5'-cyclic-AMP phosphodiesterase Sus scrofa (pig)5.835
Bile salt export pumpHomo sapiens (human)4
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)6.956
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)0.5
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.5
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)0.5
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)2.1
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)2.6333
Exopolyphosphatase PRUNE1Homo sapiens (human)0.78
Equilibrative nucleoside transporter 1Homo sapiens (human)0.0537
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)6.4

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gross, GJ; Jolly, SR2
Gross, GJ; Jolly, SR; Menahan, LA1

Other Studies

3 other study(ies) available for fr 7534 and dipyridamole

ArticleYear
Effect of FR 7534, a new calcium antagonist, on myocardial oxygen demand.
    European journal of pharmacology, 1979, Mar-01, Volume: 54, Issue:3

    Topics: Animals; Calcium; Dipyridamole; Dogs; Female; Hemodynamics; Male; Myocardium; Nifedipine; Nitroglycerin; Oxygen; Oxygen Consumption; Pyridines

1979
Improvement in ischemic myocardial blood flow following a new calcium antagonist.
    The American journal of physiology, 1980, Volume: 239, Issue:2

    Topics: Animals; Calcium; Coronary Circulation; Dipyridamole; Dogs; Dose-Response Relationship, Drug; Female; Male; Microspheres; Myocardium; Nifedipine; Nitroglycerin; Oxygen Consumption; Perfusion; Pyridines; Regional Blood Flow

1980
Effects of several calcium antagonists and dipyridamole in the isolated perfused guinea pig heart.
    Life sciences, 1980, Dec-15, Volume: 27, Issue:24

    Topics: Animals; Calcium; Coronary Circulation; Dipyridamole; Gallopamil; Guinea Pigs; Heart; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Nifedipine; Oxygen Consumption; Perfusion; Pyridines; Verapamil

1980